Minerva Neurosciences NERV
NASDAQ NERV
$2.56 +0.07 (+2.81%)
As of: Nov 11, 2026 · 3:59 PM EST

Minerva Neurosciences (NERV) Price to FCF (2017)

Updated

Minerva Neurosciences' (NERV) Price to FCF stood at 75.80 in Q4 2017, down 20.7% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Price to FCF (2017) Analysis & Trends

For FY2017, Minerva Neurosciences' Price to FCF came in at 77.10.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 75.80
Sep 30, 2017 95.59
API Access

Minerva Neurosciences Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=NERV&period=max&api_key=YOUR_API_KEY